Ke Kiʻi Ola-Neuron Protein: Nā haʻawina no ka hōʻoia ʻana i ka Peptide Probe Lepe

Pane wikiwiki

The cited FiLM approach uses fluorescent intrabodies or nanobodies, while NASTIC analyzes localization trajectories. Neither establishes a requirement for a sy…

He aha ka mea i kūkulu maoli ʻia e nā mea noiʻi o ke Kulanui o Queensland?

Huahana Peptide ʻO ka Hui Peptide maikaʻi loa Ua kūkulu ka hui ʻo Queensland i kahi kahua hōʻuluʻulu hōʻuluʻulu, ʻaʻole he microscope a ʻaʻole he ʻimi. NASTIC, pōkole no Nanoscale Spatiotemporal Indexing Clustering, lawe i ka ʻikepili localization hoʻokahi-molele a ʻike i nā nanoclusters mai nā trajectories nona nā pahu hoʻopaʻa i uhi ʻia i ka lewa a me ka manawa., me ka hoʻohana ʻana i nā ʻāpana paʻamau o r = 1.2 a me t = 20 s, a hōʻike pū ʻia nā radius puʻupuʻu, ola ana, ka helu hoʻokumu a me nā wahi wela (ka pepa hana NASTIC kumu, 2023).

Ke Kiʻi Ola-Neuron Protein: Nā haʻawina no ka hōʻoia ʻana i ka Peptide Probe Lepe

Kalepa, noho ka paepae i loko o Accretion Bio, i hoʻokumu ʻia me Professor Frederic Meunier a me Dr Tristan Wallis o ka Queensland Brain Institute, kākoʻo ʻia e UniQuest a kākoʻo ʻia e Antler (ka hui ʻo Queensland Brain Institute, 2026). Mālama ka hoʻokuʻu ʻana i ka loulou maʻi maʻamau: pili ia i nā protein kī a me nā protein pili i ka maʻi, ʻAʻole inoa i ka protein kikoʻī a ʻaʻohe helu hoʻoholo. Mālama mākou i ka ʻatikala i kēlā pae kikoʻī.

He ʻoiaʻiʻo ke kaomi ma hope o kēia hana. A 2025 Hōʻike ka wānana Global Burden of Disease i ka maʻi maʻi o Parkinson 15.6 miliona iloko 2030, 20.4 miliona iloko 2040 a 25.2 miliona iloko 2050, a 112% ala mai 2021, alakaʻi nui ʻia e ka ʻelemakule o ka lehulehu (GBD 2021 hoʻonaʻauao kuhi, 2025).

Ke Kiʻi Ola-Neuron Protein: Nā haʻawina no ka hōʻoia ʻana i ka Peptide Probe Lepe

No ke aha ka Probe, ʻAʻole ka Microscope, Hoʻopau i ka mea hiki iā ʻoe ke hoʻoholo

<papa helu ="blog-chart" kaila="laula-nui:640px;palena palena:1.5rem auto;nui-momona:12px;kiʻekiʻe laina:1.3;kala kala:hooilina"> <svg viewBox="0 0 560 380" kaila="laula-nui: 100%; kiekie: kaʻa; font-ohana: 'Inter', ʻōnaehana-ui, sans-serif; kala kala: #1e293b; --pakuhi-muted: #64748b;" kuleana="img" aria-labelledby="alzheimer-s-candidate-failure-by-phase-2002-2012-title alzheimer-s-candidate-failure-by-phase-2002-2012-desc"> <kaila> /* Hoʻokomo ka mea hāʻawi i ka pakuhi i loko o kahi iframe nona ka ʻeleʻele ʻeleʻele, a he ʻano ʻokoʻa ka iframe i ka pakuhi, no laila ua hōʻike ʻia nā pahu pahu leka me he mau papa ʻeleʻele a puni (prod 09-22). Akaka ka palapala i loko o ka iframe ma ka paʻamau; ʻO ka pena kiʻi ma ʻaneʻi e uhi ana i ke kāʻei o ka element, a ke kau ʻia ka pakuhi, ʻaʻohe mea pili kēia. E mālama i nā pale kihi ma waho o kēia poloka: ʻO kahi mea ʻano i loko o kahi SVG i hoʻokaʻawale ʻia ma ke ʻano he ʻike haole, no laila, hoʻolei kekahi bracket hele i kēlā me kēia lula i loko. */ html, kino { hope: #ffffff; palena palena: 0; } @media (makemake-hoemi-holo: hoemi) { * { hoʻouluulu: ʻaʻohe !mea nui; hoʻololi: ʻaʻohe !mea nui; } } </kaila> <pololei x="0" y="0" laula="560" kiekie="380" rx="8" hoʻopiha="#ffffff" /> <inoa id="alzheimer-s-candidate-failure-by-phase-2002-2012-title">ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae, 2002-2012</inoa> <wehewehe id="alzheimer-s-candidate-failure-by-phase-2002-2012-desc">ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae,, e like me ka manao mai ke kumu i oleloia. ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae, 2002-2012. ʻikepili pae pae: Māhele 1 72; Māhele 2 92; Māhele 3 98.Puna: Cummings, Morstorf & ʻO Zhong, Noi'i o Alzheimer & Lapaʻau 2014.</wehewehe> <kikokikona x="280.0" y="29" heleuma kikokikona="waena" font-size="18" font-kaumaha="800" hoʻopiha="kala kala">ʻO ka hāʻule ʻana o ka moho o Alzheimer ma ka pae, 2002-2012</kikokikona> <laina x1="145" y1="298.0" x2="510" y2="298.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="243.0" x2="510" y2="243.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="188.0" x2="510" y2="188.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="133.0" x2="510" y2="133.0" hahau ="kala kala" opacity="0.08" /> <laina x1="145" y1="78.0" x2="510" y2="78.0" hahau ="kala kala" opacity="0.08" /> <kikokikona x="136.0" y="122.2" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Māhele 1</tspan></kikokikona> <pololei x="145" y="78.0" laula="268.2" kiekie="68.0" rx="4" hoʻopiha="#f97316" /> <kikokikona x="421.2" y="122.2" font-size="11" hoʻopiha="kala kala">72</kikokikona> <kikokikona x="136.0" y="198.2" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Māhele 2</tspan></kikokikona> <pololei x="145" y="154.0" laula="342.7" kiekie="68.0" rx="4" hoʻopiha="#38bdf8" /> <kikokikona x="495.7" y="198.2" font-size="11" hoʻopiha="kala kala">92</kikokikona> <kikokikona x="136.0" y="274.2" heleuma kikokikona="hopena" font-size="11" hoʻopiha="kala kala" opacity="0.8"><puna x="136.0" dy="0">Māhele 3</tspan></kikokikona> <pololei x="145" y="230.0" laula="365.0" kiekie="68.0" rx="4" hoʻopiha="#a78bfa" /> <kikokikona x="518.0" y="274.2" font-size="11" hoʻopiha="kala kala">98</kikokikona> <kikokikona x="280.0" y="366" heleuma kikokikona="waena" font-size="10" hoʻopiha="kā mākou(--pakuhi-muted, kala kala)">Puna: Cummings, Morstorf & ʻO Zhong, Noi'i o Alzheimer & ʻO ka lāʻau lapaʻau (2014)</kikokikona> </svg> </huahelu>

ʻO ka hana probe kekahi mea kōkua i ka hilinaʻi kiʻi, me ka optics, loaa, hoʻolālikelike, kūlana hāpana a me ka nānā ʻana. E noʻonoʻo i ke kaulahao ana piha ma mua o ka hana ʻana i ka ʻimi noiʻi ma ke ʻano he kumu palena wale nō.

Pili ka phototoxicity i ka nalu nalu, pāʻina, ʻano hoʻolaha, ʻano kelepona a me nā lepili. ʻAʻole hiki ke hoʻololi pololei i nā paepae o Vero-cell i nā neurons. E ana i ka viability a me ka hana kūpono ma lalo o nā kūlana kūʻai maoli; ʻaʻole hiki ke ʻike ʻia nā hopena i loko o kahi ākea i hōʻoia ʻia.

Ke Kiʻi Ola-Neuron Protein: Nā haʻawina no ka hōʻoia ʻana i ka Peptide Probe Lepe

ʻO ka lepili ʻana i ka stoichiometry ka lua. ʻO ka hapa nui, ina aole pau, Hāʻawi nā hoʻolālā lepili i ka lepili substoichiometric, a hoʻolaha ʻia kahi degere ʻike maopopo ʻole o ka hōʻailona ʻana i kēlā me kēia kope-helu a i ʻole kiʻi koʻikoʻi i loaʻa mai ka fluorescence. (ka pepa lepili ProDOL, 2024). Inā ʻaʻole ʻoe i ʻike i ka nui o nā dyes e noho ana ma kēlā me kēia peptide, ʻAʻole hiki iā ʻoe ke hoʻololi i ka ikaika i nā mole.

ʻO wai nā ʻano hoʻololi Lepili-Kemika Hiki iā ʻoe ke kuhikuhi maoli?

Hiki iā ʻoe ke kuhikuhi piha i ke kemika lepili, a pono ʻoe, no ka mea, ʻaʻole hiki ke hoʻihoʻi ʻia mai ke kiʻi i hoʻopau ʻia. ʻO ke degere o ka hoʻopaʻa inoa ʻana he awelika e ana ʻia ma mua o ka manaʻo, a ʻo ka hana ProDOL e hōʻike ana he ʻokoʻa ia me ke kala, laina kelepona a me nā kūlana incubation (ka pepa lepili ProDOL, 2024).

No nā ʻimi peptide i hoʻopaʻa ʻia no ke kiʻi kiʻi ola-neuron, ʻO nā mea hoʻololi e hoʻololi i ke ana ʻo ia ka ʻike wai, lākiō wai-i-peptide, kahua hui, ka lōʻihi o ka loulou a me ke kemika, a pehea e wehe ʻia ai ke koena wai waihoʻoluʻu. Hoʻololi kēlā me kēia i ka mālamalama, kinai ʻana a i ʻole ka hope, a aia kēlā me kēia ma ka kikoʻī ma mua o ke kamaʻilio ʻana.

Hoʻololi

No ke aha ia e hoʻololi ai i ke ana

He aha e noi ai i ka mea hoʻolako e palapala

ʻIke ʻike wai

ʻO ka hauʻoli a me ka hoʻokuʻu, ʻokoʻa ka photostability a me ka hanauna ROS e ka wai

inoa kala, hailona, hauʻoli a me ka hoʻokuʻu maxima

Wailu-i-peptide Hale Hana kuai nui Peptides ratio

Hoʻonohonoho i ka mālamalama no kēlā me kēia mole a me ka pilikia o ka hoʻopau ʻana iā ia iho

Lakiō ana me ke ʻano i hoʻohana ʻia

Paena huikau

N-terminal, Hiki ke hoʻololi i ke kaulahao ʻaoʻao a i ʻole C-terminal lepili

Paena o ka hoʻopili, hōʻoia ʻia e MS/MS

Mea hoʻopili

Hoʻopili ka lōʻihi a me ka kemika i ka hiki a me ka hōʻuluʻulu

ʻO ke ʻano o ka loulou a me ka hana cleavage

Waikani manuahi Peptides Pākē ka wehe ʻana

Hoʻonui ka waihoʻoluʻu koena i ke kua a me ka hōʻailona punctate

Kaʻina hoʻomaʻemaʻe a me ka nānā ʻana i ka waihoʻoluʻu

Maʻemaʻe a me ka ʻike

ʻAʻole hōʻoia ka helu HPLC hoʻokahi i ka conjugate

Hana HPLC me LC-MS o ka conjugate

ʻO kā mākou hana hōʻailona peptide fluorescent e uhi i ka FITC, FAM, TAMRA, Cy3, Nā lepili Cy5 a me Cy7 me ka papa kuhikuhi hoʻololi ākea, me ka N-terminal acetylation, biotinylation, PEGylation, phosphorylation, cyclization a me nā lepili isotopic. He mea nui kēlā papa kuhikuhi ma ʻaneʻi no ka mea he hoʻoholo hoʻolālā ka pūnaewele conjugation, ʻaʻole he manaʻo hope.

Pehea ka maemae, ʻIkepili, Maʻiʻo, 'Oko'a ka Pa'a a me ka Ho'ā'o?

ʻElima mau nīnau kaʻawale, a ʻo ka palapala hōʻoia e pane i kekahi, ʻaʻole i pane i kekahi o nā mea ʻē aʻe. ʻO nā ʻāpana kikoʻī ma I Q6B helehelena kaawale, ʻike ʻike, ka maemae a me ka haumia, ka mana a me ka nui, me ke kūpaʻa e like me ke kumu no ka hoʻonohonoho ʻana i nā kikoʻī (1999). Nīnau ke alakaʻi like ʻana e kikoʻī loa nā hoʻāʻo ʻike i nā ʻano kūʻokoʻa o ke ʻano molekala, a me ka hoʻomaopopo ʻana he paʻakikī ka hoʻomaʻemaʻe piha ʻana a hilinaʻi nui i ke ʻano hana, no laila ua manaʻo ʻia ka maʻemaʻe mai ka hui pū ʻana o nā ʻano hana.

ʻO ia ka hoʻoponopono i ka maʻamau o ka ʻae ʻana i hoʻokahi helu HPLC ma ke ʻano he hailona. ʻAʻole helu ka wai a me nā paʻakai ka hoʻomaʻemaʻe peptide e HPLC, ka mea komo ole kokoke 220 nm, a ʻo ka helu maʻemaʻe kiʻekiʻe he liʻiliʻi me ka ʻike ʻole i hoʻopaʻa ʻia. ʻO ka hoʻāʻo analytical Orthogonal o nā peptides e pani i ke āpau: I Q2(R2) ʻae ʻia e hōʻike ʻia ka kikoʻī e kūʻē i kahi kaʻina hana orthogonal a paipai i ʻelua a ʻoi aku paha nā kaʻina hana inā ʻaʻole lawa kekahi (hāpai ʻia ʻo Nowemapa 2023). Ma ka hana, e hoʻopili i ka RP-HPLC me kahi kolamu i ʻōlelo ʻia, gradient a me ka loaʻa ʻana o ka nalu me LC-MS no ka ʻike a me kahi ʻike ʻike no ka peptide net.

Ma kahi e kākoʻo ai nā moʻolelo uila i ka hoʻouna i hoʻoponopono ʻia, 21 Mahele CFR 11 hoʻonohonoho i nā pae hoʻohālike e mālama ai ka FDA iā lākou ma ke ʻano he mea hilinaʻi a pono e palekana, nā ala hoʻokele manawa. E noi i ka ʻano peptide fluorescent e kapa inoa i kēlā me kēia ʻano, ʻaʻole hoʻokahi hopena.

ʻO wai nā mana e hiki ke pale aku i ka hoʻopiʻi hoʻopaʻa ʻana ma muli o ke kiʻi?

ʻAe ka mea loiloi i kahi koi hoʻopaʻa ʻana ke kāpae ʻia nā mana i ka mea hana reagent, ʻaʻole i ka wā e kū ana ke kiʻi. Hoʻonohonoho nā pae hoʻohālikelike no ka ʻimi kemikala i ka pa e pono ai ka ʻimi ponoʻī: ka mana ma lalo 100 nM i nā hoʻokolohua biochemical a ma lalo 1 µM i loko o nā pūnaewele, koho ʻoi aku ma mua o 30-fold i loko o ka ʻohana i manaʻo ʻia, a me nā hōʻike pololei o ke komo ʻana o ka pahuhopu i nā cell (ʻO ke au o nā ʻimi kemika kiʻekiʻe, 2022). Hoʻopaʻa ka loiloi like i ka nāwaliwali, ʻO nā pūhui koho ʻole i hoʻopuka i ka nui o nā manaʻo kuhi hewa i ka palapala, ʻo ia ke kumu o ka mana i hoʻonohonoho ʻia ma lalo nei ka ʻāpana o kahi pūʻolo a mākou e nīnau mua ai.

ʻO ke alakaʻi hōʻoia a ka Chemical Probes Portal e mālama i kahi reagent i hōʻailona ʻia ma ke ʻano he mea pono e hele ma ke ʻano he reagent ana a me kahi noiʻi kemika.: hōʻailona hilinaʻi pahuhopu ma lalo o nā kūlana hoʻāʻo, hoʻopaʻa ʻana i nā ʻike hiki ke hoʻohana, koho, a me kahi loulou mai ka hoʻopili ʻana i ka hana. ʻAʻole loaʻa kahi hōʻailona ʻālohilohi a i ʻole biologically active nona iho (Nā nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau nīnau kiʻi, 2021).

ʻO nā mana ʻelima a mākou e noi ai e ʻike

  • Hoʻohālikelike ʻia ka peptide ʻole i hōʻailona ʻia, ke kaʻina like a me ka hailona

  • ʻO ka peptide mana maikaʻi ʻole, ʻāwili a paʻa ʻole paha

  • ʻO nā lima kala wale a me ka lepili wale nō i ka manaʻo kūlike

  • Kūlana-ʻole a paʻa ʻole ke kūlana

  • Hōʻoia ʻo Orthogonal o ka hoʻopaʻa ʻana, kūʻokoʻa i ka fluorophore

E hoʻohana i nā mana i kūpono i ka koi a me ka ʻōlelo ʻana i nā mea ʻē aʻe i hoʻoholo ʻole ʻia. Hiki ke kaupalena ʻia ka hilinaʻi i ka mana i manaʻo ʻia, akā, ʻaʻole ia e hōʻemi i kēlā me kēia hopena i ka fluorescence nonspecific i ka wā e kamaʻilio ai nā hōʻike kūpono ʻē aʻe i ka maopopo ʻole.. Hoʻokumu Peptide M Peptides Mea Hana

He aha kēia e hoʻololi ai no nā papahana a Alzheimer a me Parkinson, a he aha kāu e wehewehe ai i ke kauoha ʻana?

kahi palapala kikoʻī kikoʻī o ka nānā ʻana i waiho ʻia ma ka ʻaoʻao o kahi hue peptide i hōʻailona ʻia, me nā laina ala (RP-HPLC me ke kolamu

Kuhi ʻia ka maʻi maʻi Parkinson honua Manaʻo ʻia ka piʻi ʻana o ka maʻi Parkinson mai 15.6 miliona iloko 2030 i 20.4 miliona iloko 2040 a 25.2 miliona iloko 2050. Kuhi ʻia ka maʻi maʻi Parkinson honua. ʻikepili laina: 2030 15.6; 2040 20.4; 2050 25.2.Puna: ʻO ke aʻo ʻana o ka prevalence projection o Parkinson (PMC) 2025-03-05. Kuhi ʻia ka maʻi maʻi Parkinson honua 0 12.5 25 37.5 50 15.6 2030 20.4 2040 25.2 2050 Puna: ʻO ke aʻo ʻana o ka prevalence projection o Parkinson (PMC) (2025-03-05)

Hoʻololi ia i ke kūlana hōʻike ma mua o ka ʻike, ʻaʻole ka biology maʻi. Ua loaʻa kahi helu helu ʻumi makahiki o nā hoʻāʻo o Alzheimer 244 nā pūhui i hoʻāʻo ʻia ma waena 2002 a 2012 me kekahi i aponoia, a 0.4% ka holomua holomua, a 72% o nā moho hāʻule i ka Phase 1, 92% i ka Phase 2 a 98% i ka Phase 3 (he ʻumi makahiki ka lōʻihi o ka helu ʻana o nā hoʻokolohua Alzheimer, 2014). Hana ʻia ka hapa nui o ka attrition ma mua o ka hale lapaʻau lohi, kahi pono kahi mechanistic, Pono e loaʻa i ka heluhelu ʻana i ke kelepona ola.

Ke kauoha ʻoe i kahi hōʻailona peptide probe no kēia hana, e kuhikuhi i ka pūʻolo, ʻaʻole wale ke kaʻina. E noi i ka pūnaewele conjugation a me ka loulou, ke ana ʻia ka lākiō dye-to-peptide me kona ʻano, LC-MS o ka conjugate, RP-HPLC me ke kolamu, i ʻōlelo ʻia ka gradient a me ka lōʻihi nalu, maʻiʻo peptide net, counterion a me ke koena TFA, he nānā hoʻoheheʻe i loko o kāu pale hoʻāʻo, a me kahi hōʻike paʻa.

Inā ʻo kou kūlana

A laila koi

E hoʻololi ʻia ka hōʻailona i ka helu kope

Ana ʻia ka dye-to-peptide ratio me ka mana hoʻopaʻa inoa

Holo ka Assay ma kahi kokoke i ka palena o ka hiki

ʻO ka maʻemaʻe conjugate i kākau ʻia a me ka ʻike, ʻaʻole hapa pākēneka wale nō

Loaʻa ka loaʻa ola lōʻihi a i ʻole

Ua hōʻike ʻia ka nui māmā a me ka mana phototoxicity

Hoʻopaʻa haʻawina nui-nui a i ʻole ka nui-pae

ʻO CoA kikoʻī nui me nā mea ʻike ala a me kahi ʻaoʻao paʻa

Manaʻo ʻia ka waiho ʻana i hoʻoponopono ʻia

Nā moʻolelo uila i hoʻopaʻa ʻia ma lalo 21 Mahele CFR 11

Hoʻokele ʻo MOL Changes i nā hui kūlohelohe a me nā hui ola i loko o ka hale, me ka pae paʻa, wai-wai a hui pū ʻia me ka microbial fermentation, a me ka hana ʻana mai ka milligram a hiki i ka paona kilo. No ka hana ʻimi noiʻi ʻo ia hoʻi ka hoʻololi, hiki ke kuhikuhi pū ʻia ka lepili fluorescent a me ka pūʻolo analytical, me ka hoʻāʻo pinepine ʻana ma kēlā me kēia kaʻina hana a me nā palapala kikoʻī he nui.

Nīnau pinepine

He kiʻi hoʻomaʻemaʻe HPLC kiʻekiʻe i lawa no ka hoʻokō ʻana i kahi ʻāpana noiʻi?

ʻAʻole. ʻO ka maʻemaʻe e hilinaʻi nui ʻia i ke ʻano a ua manaʻo ʻia e ka hui pū ʻana o nā ʻano hana (I Q6B, 1999). Wahi pakeneka ma 220 hoole nm ka wai a me ka paakai, no laila e hui pū me ka ʻike LC-MS a me kahi ʻike ʻike.

He aha kaʻu palapala e noi mua ai?

ʻO ka palapala hōʻoia kikoʻī kikoʻī o ka nānā ʻana me nā ʻano ʻike: kolamu, gradient, lōʻihi nalu, ʻO ke ʻano MS a me ka lakio hōʻailona. ʻAʻole hiki ke hana hou a pale ʻia paha kahi hopena me ka ʻole o kāna ʻano.

Ka hopena

He maʻalahi ka lula hoʻoholo a mākou e hoʻohana ai. E ʻae nui i ka wā e hōʻoia ʻia ai ka ʻike e ka mass spectrometry, hōʻike ʻia ka maʻemaʻe me kāna ʻano hana a hui pū ʻia me kahi ʻike ʻike, ana ʻia ka lākiō dye-to-peptide, loaʻa kahi mana hōʻailona-efficiency, a ua hōʻike ʻia ka nui māmā me ka nānā ʻana i ka phototoxicity. Hoole, a i ʻole e koho hou, ke nalowale kekahi o ia mau mea, no ka mea, e ʻike mau ana ke kiʻi.

Inā ʻoe e kūkulu nei i kahi papahana kiʻi kiʻi ola-neuron e pili ana i nā probes peptide i kapa ʻia, hiki i kā mākou hui ke hoʻohui i kahi pūʻolo hōʻoia hōʻoia a me kahi laʻana CoA kikoʻī e pili ana i kēia mau pae. E haʻi mai iā mākou i kāu kaʻina, lepili a me ka ho'āʻo hoʻopaʻa, a e haʻi mākou iā ʻoe i ka mea hiki a hiki ʻole ke kākoʻo i ka palapala.

Hōʻike ka mea hoʻopuka: Hāʻawi ʻo MOL Changes i nā lawelawe peptide a he hoihoi koʻikoʻi i kēia kumuhana. ʻO nā lālā lawelawe a me nā ʻōlelo hiki ke koi i nā mea hoʻolako; ʻO ka loaʻa a me ka hana ʻana no kahi kūkulu kikoʻī e koi i nā hōʻike kikoʻī o ka papahana.

Xiaoxia Chen

Xiaoxia Chen

Laau Laau Hou R&D ʻenehana Kaʻike kumu: Loaʻa ka pahuhopu, pilina hana-hana (SAR) kālailai, peptide-lāʻau conjugates (Nā PDC), a me ka hoʻomohala ʻana i nā peptides anti-kahiko a me ka metabolic.

Pilikino: Ua alakaʻi ʻo Xiaoxia Chen i ka ʻike mua ʻana a me ka noiʻi preclinical no kekahi mau lāʻau peptide metabolic a me ka tumor-targeted.. ʻAʻole wale ʻo ia i mākaukau i ka nānā ʻana i nā hale waihona puke peptide, akā akamai nō hoʻi i ka hoʻohana ʻana i ka biology computational kōkua AI no ka hoʻolālā ʻana o ka de novo peptide sequence.. I kēia manawa, ke alakaʻi nei ʻo ia i kahi hui i hoʻolaʻa ʻia i ka noiʻi hohonu a me ka hoʻomohala ʻana o nā agonists multifunctional hanauna hou (like me pālua- a i ʻole nā ​​peptides hoʻohaʻahaʻa momona ʻekolu) a me nā peptides hoʻoponopono hou i ke kino.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana